← Open Payments lookup

MICHAEL HORD: Open Payments

NPI 1205864626 · BROWNFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,817 in 103 payments from 23 companies in 2025. Trend: 2023 $1,839 · 2024 $1,800 · 2025 $1,817

Food & beverage: $1,817
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$190
GlaxoSmithKline, LLC.17$185
Novo Nordisk Inc10$164
Axsome Therapeutics, Inc.9$162
Bayer Healthcare Pharmaceuticals Inc.8$153
Lilly USA, LLC7$118
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$117
Sumitomo Pharma America, Inc.5$106
Aimmune Therapeutics, Inc.4$97
Otsuka America Pharmaceutical, Inc.3$75

Products named: Auvelity, Kerendia, TRELEGY ELLIPTA, MOUNJARO, XIFAXAN, FARXIGA, GEMTESA, REXULTI.

Industry payments across TX — which companies pay providers there.